Consumer expectations are evolving
John Salerno designed his Chelation IV treatment with Dimercaptopropane Sulfonic Acid, to help patients eliminate heavy metals, such as lead, mercury, arsenic, and cadmium, that can accumulate in the body due to environmental exposure, occupational hazards, or dietary sources
This is due to the possibility that more glycine and serine may be needed to properly catabolize the extra methionine, unintentionally leading to a shortage in these amino acids
23 a recent paper challenged the specificity of the used antibody, 11 questioning the validity of the data of this study
la deildir
Kran T, Otlu O, Karabulut A